Skip to content

Effect of subanesthetic dose esketamine postoperative sleep disturbance in Patients Undergoing thoracoscopic lobectomy

Effect of subanesthetic dose esketamine postoperative sleep disturbance in Patients Undergoing thoracoscopic lobectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086246
Enrollment
Unknown
Registered
2024-06-27
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative sleep disturbance

Interventions

C group:General anesthesia + intraoperative infusion of physiological saline + postoperative pain relief with sufentanil
S group:General anesthesia +intraoperative infusion of esketamine + postoperative analgesia with a combination of sufentanil and esketamine.

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for elective thoracoscopic lobectomy; 2.Male or female, aged 18-75 years, ASA classification I-III, BMI 18-30 kg/m²; 3. Subjects voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to or contraindicated for the study drug; 2. Contraindications to regional or general anesthesia; 3. Poorly controlled or untreated hypertension; 4. Poorly controlled blood glucose (random blood glucose =11.1 mmol/L); 5. Significant abnormalities in preoperative liver function (AST or ALT =1.5×ULN; TBIL =1.5×ULN) and/or kidney function (Cr =1.5×ULN); 6. Pregnant or lactating women; 7. Conversion to open thoracotomy or occurrence of severe adverse events during surgery; 8. Combined psychiatric or neurological disorders; 9. Surgery ending later than 19:00 on the same day; 10. History of previous chest surgery or chest trauma; 11. Inability or refusal to cooperate; 12. Other conditions deemed unsuitable for participation in this clinical trial by the investigator.

Design outcomes

Primary

MeasureTime frame
The incidence of Postoperative sleep disturbance;

Secondary

MeasureTime frame
Postoperative VAS scores;Postoperative anxiety and depression scores;The incidence of postoperative delirium;Postoperative morphine consumption.;Consumption of opioid analgesics during surgery;Postoperative serum inflammatory factors;Consumption of vasopressor drugs during surgery.;

Countries

China

Contacts

Public ContactShan Guoliang;Jin Yanwu

The Second Hospital of Shandong University

646495853@qq.com+86 182 6533 8415

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026